Psychiatry and Neurology, Neurology · Albany, NY
NPI
1366685802
Since 2009
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
43 New Scotland Ave # Mc-70
Albany, NY, 12208
Phone (518) 262-5226
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
468 services
Medicare patients, 2024
198
Average age 72
Drug cost, 2024
$3.0M
859 prescriptions
Company payments, 2025
$216
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kimberly R Robeson-Gewuerz was code 99232 (hospital e&m - subsequent), 67 times for 34 patients. In total Kimberly R Robeson-Gewuerz billed 468 services in 29 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-10-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 67 | 34 | $58.10 | $3,893 |
| 99214 Office E&M - Established | Facility | 50 | 39 | $64.74 | $3,237 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 45 | 30 | $12.17 | $547 |
| 99214 Office E&M - Established | Office | 40 | 31 | $64.63 | $2,585 |
| 99231 Hospital E&M - Subsequent | Facility | 33 | 15 | $37.15 | $1,226 |
| 95886 Electrical Nerve Conductivity | Facility | 29 | 21 | $29.11 | $844 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 24 | 19 | $11.41 | $274 |
| 99222 Hospital E&M - Initial | Facility | 22 | 22 | $93.71 | $2,062 |
| 99205 Office E&M - New | Facility | 22 | 22 | $120.35 | $2,648 |
| 99238 Hospital Discharge Management | Facility | 20 | 20 | $60.90 | $1,218 |
| 99204 Office E&M - New | Facility | 16 | 16 | $93.84 | $1,501 |
| 95911 Electrical Nerve Conductivity | Facility | 16 | 16 | $84.82 | $1,357 |
| 99215 Office E&M - Established | Facility | 13 | 12 | $100.09 | $1,301 |
By year: 2022 $28K for 426 services; 2023 $25K for 375 services; 2024 $27K for 468 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kimberly R Robeson-Gewuerz prescribed most often to Medicare patients was Gabapentin, with 109 prescriptions and refills. In total Kimberly R Robeson-Gewuerz wrote 859 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 109 | 143 | 22 | $1,922 |
| Prednisone Generic | 91 | 108 | 16 | $460 |
| Duloxetine Hcl Generic | 87 | 131 | 14 | $952 |
| Pyridostigmine Bromide Generic | 66 | 116 | 22 | $4,331 |
| Hizentra Immun Glob G(Igg)/Pro/Iga 0-50 | 53 | 53 | Under 11 | $754K |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 48 | 48 | Under 11 | $605K |
| Pregabalin Generic | 47 | 57 | Under 11 | $1,770 |
| Mycophenolate Mofetil Generic | 44 | 69 | 11 | $3,212 |
| Azathioprine Generic | 33 | 45 | Under 11 | $562 |
| Diazepam Generic | 31 | 31 | Under 11 | $148 |
| Riluzole Generic | 29 | 39 | Under 11 | $3,805 |
| Gammaplex Immun Glob G(Igg)/Gly/Iga 0-50 | 26 | 26 | Under 11 | $348K |
| Sodium Chloride 0.9 % Sodium Chloride | 26 | 26 | Under 11 | $326 |
| Radicava Ors Edaravone | 25 | 25 | Under 11 | $361K |
| Baclofen Generic | 23 | 32 | Under 11 | $226 |
Brand drugs: 239 claims; generic drugs: 620 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kimberly R Robeson-Gewuerz $216 ($216 in general payments such as food, travel and fees) from 5 companies. The largest payer was UCB, Inc. with $133.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.